Psychometric Evaluation of the Chinese Version of the Resilience Scale-10 for Cancer Children
NCT03544190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186
Last updated 2021-04-29
Summary
This study aims to translate the original English version of Resilience Scale for Children (RS10) into traditional Chinese. It will then test the psychometric properties of the newly translated RS10.
Conditions
- Cancer Childhood
Sponsors & Collaborators
-
The University of Hong Kong
lead OTHER
Principal Investigators
-
Oi Kwan Joyce Chung, Dr · The University of Hong Kong
Eligibility
- Min Age
- 7 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-28
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSs
NCT07052110 ·Status: RECRUITING ·Phase: NA
-
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
NCT06718972 ·Status: RECRUITING
-
Association of Psychological Distress in Patients With Lung Cancer
NCT06218901 ·Status: RECRUITING
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Development of a Scale for Cancer Patients' Willingness to Voluntarily Participate in Drug Clinical Trials
NCT06120335 ·Status: RECRUITING
-
Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
NCT05468970 ·Status: RECRUITING
-
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197 ·Status: RECRUITING
-
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
NCT05477979 ·Status: RECRUITING
-
Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer
NCT00563420 ·Status: COMPLETED ·Phase: NA
-
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population
NCT03893929 ·Status: RECRUITING
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
Psychometric Properties of the EORTC QLQ-LC29
NCT02745691 ·Status: COMPLETED
-
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
NCT06377124 ·Status: RECRUITING ·Phase: NA
-
Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer
NCT06349252 ·Status: RECRUITING
-
Impact of Psychological Stress on Treatment Response and Prognosis in Lung Cancer Patients
NCT06964503 ·Status: NOT_YET_RECRUITING
-
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer
NCT05252065 ·Status: UNKNOWN
-
Acupressure for Cough in Lung Cancer Survivors
NCT07315672 ·Status: RECRUITING ·Phase: NA
-
Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy
NCT04741633 ·Status: UNKNOWN
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
NCT05761093 ·Status: RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients
NCT03290001 ·Status: UNKNOWN
-
Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients
NCT07170059 ·Status: NOT_YET_RECRUITING
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN
-
A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer
NCT01731548 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3